111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Update

111, Inc. Sponsored ADR (NASDAQ:YI) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 35,430 shares, a growth of 2,235.5% from the December 31st total of 1,517 shares. Based on an average trading volume of 113,328 shares, the short-interest ratio is presently 0.3 days. Approximately 0.7% of the shares of the company are short sold. Approximately 0.7% of the shares of the company are short sold. Based on an average trading volume of 113,328 shares, the short-interest ratio is presently 0.3 days.

111 Trading Up 4.8%

Shares of NASDAQ:YI traded up $0.24 during mid-day trading on Tuesday, reaching $5.25. The stock had a trading volume of 15,320 shares, compared to its average volume of 67,375. The business’s 50 day moving average price is $3.80 and its 200 day moving average price is $5.00. 111 has a 1 year low of $2.48 and a 1 year high of $11.35. The company has a market cap of $45.36 million, a P/E ratio of -6.25 and a beta of 0.51.

111 (NASDAQ:YI) last posted its quarterly earnings data on Wednesday, December 17th. The company reported ($1.20) EPS for the quarter. The business had revenue of $421.49 million for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 111 in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.